Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Grifols Australia Pty Ltd.

Home Clinical Trial Sponsors and OrganizationsGrifols Australia Pty Ltd.

Grifols Australia Pty Ltd.

ACTIVE

Australiawww.grifols.com/en/australiaSubsidiary

Part of 基立福

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

0

0 active

Approvals

67

Total approvals

Agencies

1

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

No trial phase data available

Trial Status Distribution

No trial data available

Clinical Trials

No trial data available

Approvals

Approvals by Agency

TGA

Therapeutic Goods Administration

67

Approvals

Recent Approvals

Grifols Australia Pty Ltd - Instrument/analyser IVDs (530685)

GAMUNEX normal immunoglobulin (Human) 40g/400mL Intravenous solution vial (371434)

GAMUNEX normal immunoglobulin (Human) 40g/400mL Intravenous solution vial (371434)

XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial (380406)

XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial (380404)

XEMBIFY normal immunoglobulin 2 g/10 mL (20%) solution for subcutaneous injection vial (355315)

XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial (380404)

XEMBIFY normal immunoglobulin 1 g/5 mL (20%) solution for subcutaneous injection vial (380405)

XEMBIFY normal immunoglobulin 1 g/5 mL (20%) solution for subcutaneous injection vial (380405)

XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial (380406)

News

No news articles found

On this page

Overview
Clinical Trials
Approvals67
News

Back to Organizations